Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.54, Iss.5, 1999-11, pp. : 780-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?

By Ohori M. Dunn J.K. Scardino P.T.

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 666-671

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? part I: framing the debate

By Barry M.J. Fleming C. Coley C.M. Wasson J.H. Fahs M.C. Oesterling J.E.

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 2-13

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen best practice policy-part I: early detection and diagnosis of prostate cancer

By Carroll P. Coley C. McLeod D. Schellhammer P. Sweat G. Wasson J. Zietman A. Thompson I.

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: early detection strategies

By Coley C.M. Barry M.J. Fleming C. Wasson J.H. Fahs M.C. Oesterling J.E.

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 125-141

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program

By Barry M.J. Fleming C. Coley C.M. Wasson J.H. Fahs M.C. Oesterling J.E.

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 445-461

Elsevier

Access to resources Recommend Favorite